D 69, 12041214
Constipation typically improves within 612 weeks as your digestive system adapts
The antibody simtuzumab, targeting extracellular LOXL2, has undergone clinical trials in combination with gemcitabine for patients with metastatic pancreatic adenocarcinoma or with FOLFIRI (folinic acid, fluorouracil, and irinotecan) for patients with KRAS mutant colorectal cancer [102, 103]
The mechanism of post-prandial increase in GLP-1 level following MBS can be explained by faster gastric emptying and rapid delivery of nutrients to the intestine, exclusion of foregut, and changes in bile acids metabolism [18, 24]
Radioprotective agents have shown to reduce DNA damage in vitro, in vivo, and in human randomized controlled trials
The side effects, while common, were overwhelmingly manageable